1. Home
  2. STRA vs AGIO Comparison

STRA vs AGIO Comparison

Compare STRA & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STRA

Strategic Education Inc.

HOLD

Current Price

$80.32

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$28.12

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRA
AGIO
Founded
2017
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
STRA
AGIO
Price
$80.32
$28.12
Analyst Decision
Buy
Buy
Analyst Count
2
8
Target Price
$96.50
$37.63
AVG Volume (30 Days)
302.2K
662.0K
Earning Date
04-23-2026
04-30-2026
Dividend Yield
2.98%
N/A
EPS Growth
15.85
N/A
EPS
5.41
N/A
Revenue
$997,137,000.00
$43,011,000.00
Revenue This Year
$4.71
$75.68
Revenue Next Year
$2.48
$167.63
P/E Ratio
$14.85
N/A
Revenue Growth
57.23
N/A
52 Week Low
$72.17
$22.24
52 Week High
$92.98
$46.00

Technical Indicators

Market Signals
Indicator
STRA
AGIO
Relative Strength Index (RSI) 50.00 48.10
Support Level $79.98 $26.48
Resistance Level $84.71 $29.49
Average True Range (ATR) 3.18 1.10
MACD -0.01 -0.04
Stochastic Oscillator 35.02 35.30

Price Performance

Historical Comparison
STRA
AGIO

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: